ArticleAnnals of clinical microbiology and antimicrobials2020

Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection.

Ouli Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.